US FDA warns Pfizer over tardy pharmacovigilance

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2010年 / 1306卷 / 1期

关键词：

Public Health; Legal Action; Chief Executive; Potential Side Effect; Timely Fashion;

D O I：

10.2165/00128415-201013060-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[21] Brazilian diet pills may be harmful, warns US FDA
[J]. Reactions Weekly, 2006, 1085 (1) : 3 - 3
[22] US FDA warns of injection-site reactions with naltrexone
[J]. Reactions Weekly, 2008, 1216 (1) : 5 - 5
[23] Pfizer and Novartis seek US FDA approval for their MenB vaccines
不详
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2779 - 2779
[24] US FDA warns of high estrogen levels with Ortho Evra Patch
[J]. Reactions Weekly, 2005, 1078 (1) : 2 - 2
[25] US FDA warns doctors to use cisapride as last resort only
Ault, A
[J]. LANCET, 1998, 352 (9122): : 120 - 120
[26] US FDA warns companies to stop distributing unapproved prescription narcotics
[J]. Reactions Weekly, 2009, 1247-1248 (1) : 3 - 3
[27] Oral sodium phosphates: acute renal failure risk, warns US FDA
[J]. Reactions Weekly, 2006, 1101 (1) : 2 - 2
[28] US FDA warns public about new butyrolactone-related agents
[J]. Reactions Weekly, 1999, 752 (1) : 3 - 3
[29] US FDA warns of possible EpiPen auto-injector errors/malfunction
[J]. Reactions Weekly, 2020, 1798 (1) : 1 - 1
[30] US FDA warns manufacturers about illegal steroid-containing products
[J]. Reactions Weekly, 2006, 1093 (1) : 2 - 2

← 1 2 3 4 5 →